References
- Anderson JM, Milner RD, Strich SJ. Effects of neonatal hypoglycaemia on the nervous system: a pathological study. J Neurol Neurosurg Psychiatry. 1967;30(4):295–310.
- Banker BQ. The neuropathological effects of anoxia and hypoglycemia in the newborn. Dev Med Child Neurol. 1967;9(5):544–550.
- Cornblath M, Schwartz R. Outcome of neonatal hypoglycaemia. Complete data are needed. BMJ. 1999;318(7177):194–195.
- Duvanel CB, Fawer CL, Cotting J, et al. Long-term effects of neonatal hypoglycemia on brain growth and psychomotor development in small-for-gestational-age preterm infants. J Pediatr. 1999;134(4):492–498.
- Lucas A, Morley R, Cole TJ. Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia. BMJ. 1988;297(6659):1304–1308.
- Rozance PJ, Hay WW Jr. New approaches to management of neonatal hypoglycemia. Matern Health Neonatol Perinatol. 2016;2:3.
- Gyamfi-Bannerman C, Thom EA, Blackwell SC, et al. Antenatal betamethasone for women at risk for late preterm delivery. N Engl J Med. 2016;374(14):1311–1320.
- Redlich A, Böttger R, Costa SD. Antenatal betamethasone for women at risk for late preterm delivery. N Engl J Med. 2016;375(5):486.
- Pedersen J. Diabetes and pregnancy: blood sugar of newborn infants. Ph.D. Thesis. Danish Science Press. p. 230; 1952.
- Taipale P, Hiilesmaa V. Predicting delivery date by ultrasound and last menstrual period in early gestation. Obstet Gynecol. 2001;97(2):189–194.
- Gardosi J. Dating of pregnancy: time to forget the last menstrual period. Ultrasound Obstet Gynecol. 1997;9(6):367–368.
- Harris DL, Weston PJ, Harding JE. Incidence of neonatal hypoglycemia in babies identified as at risk. J Pediatr. 2012;161(5):787–791.
- American College of Obstetricians and Gynecologists’ Committee on Obstetric Practice, Society for Maternal–Fetal Medicine. Committee opinion No.677: antenatal corticosteroid therapy for fetal maturation. Obstet Gynecol. 2016;128(4):e187–e194.
- Jolley JA, Rajan PV, Petersen R, et al. Effect of antenatal betamethasone on blood glucose levels in women with and without diabetes. Diabetes Res Clin Pract. 2016;118:98–104.
- Shelton SD, Boggess KA, Smith T, et al. Effect of betamethasone on maternal glucose. J Matern Fetal Neonatal Med. 2002;12(3):191–195.
- Handwerger S, Freemark M. The roles of placental growth hormone and placental lactogen in the regulation of human fetal growth and development. J Pediatr Endocrinol Metab. 2000;13(4):343–356.
- Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics. 1972;50(4):515–525.
- Stutchfield P, Whitaker R, Russell I, et al. Antenatal betamethasone and incidence of neonatal respiratory distress after elective caesarean section: pragmatic randomised trial. BMJ. 2005;331(7518):662.
- Stutchfield PR, Kotecha S, Doull IJ. Antenatal betamethasone for women at risk for late preterm delivery. N Engl J Med. 2016;375(5):485–486.
- Rokicki W, Krasnodebski J. Antenatal glucocorticoid administration and neonatal glycemia. Dev Pharmacol Ther. 1987;10(4):307–311.
- Pettit KE, Tran SH, Lee E, et al. The association of antenatal corticosteroids with neonatal hypoglycemia and hyperbilirubinemia. J Matern Fetal Neonatal Med. 2014;27(7):683–686.
- Porto AM, Coutinho IC, Correia JB, et al. Effectiveness of antenatal corticosteroids in reducing respiratory disorders in late preterm infants: randomised clinical trial. BMJ. 2011;342:d1696.